Key Takeaways

  • Children's Healthcare of Atlanta (CHOA) runs a 70/30 portfolio where approximately 35% is committed to technology and healthcare assets.
  • Senior Managing Director Zack McGuire and CFO Ruth Fowler built the Healthcare Advisory Committee two years ago to connect the investment team to clinical and administrative leadership.
  • The investment office acts as a dual-sided filter: hospital operators preview external software and medical tools early, while private venture and growth managers get direct validation from pediatric clinicians.
  • Unlike traditional university endowments isolated in separate offices, CHOA treats internal enterprise challenges as test cases to vet external managers and portfolio companies.

The Wall Between Endowments and Operations Has Cracked

University endowments historically pride themselves on isolation. They sit in separate buildings or distant cities, chasing pure financial returns while keeping campus administration at arm's length. Zack McGuire saw that model up close before joining Children's Healthcare of Atlanta. At CHOA, that wall does not exist.

“We're closely integrated in the system, which may be one of the biggest differences that I've noticed between being at a university endowment and a hospital system,” (play from 28:21) McGuire explains. “We inherently are part of the system and we're there to serve the mission and contribute in any way that we can.” (play from 28:31)

The baseline goal remains financial performance. CHOA operates a dynamic 70/30 portfolio construction, relying on a generalist team organized by majors and minors. But pure balance sheet management leaves value on the table when an institution purchases billions in clinical supplies, software, and real estate. Two years ago, McGuire and CHOA CFO Ruth Fowler established the Healthcare Advisory Committee. The goal was direct: turn the investment office into an intelligence pipeline for hospital executives, clinical staff, and medical researchers.

Turning GP Due Diligence into Hospital Operating Alpha

Roughly 35% of CHOA's aggregate portfolio sits in technology and healthcare. That concentration gives McGuire's team early looks at private market software, artificial intelligence applications, and clinical tools long before they hit procurement desks.

“That provides us quite an expansive view outside our four walls,” (play from 51:50) McGuire notes. “Through that portfolio, we have incredible access to investors, companies, experts, regulators, policymakers that are operating at the intersection of technology and healthcare.” (play from 51:55)

Instead of hoarding that access, the investment office routes deal flow through the Healthcare Advisory Committee. If a venture capital or private equity manager is evaluating a commercial-stage healthcare company, McGuire connects them directly with CHOA's department heads. The manager gets instant, high-stakes diligence from an actual enterprise buyer.

“There's been instances of doing due diligence on a venture capital manager, or maybe they're doing due diligence on a portfolio company, I can put them in touch with somebody internally,” (play from 54:16) McGuire says. “Is this company working on a problem that you, as a leading pediatric healthcare system, value and you'd be willing to pay for? And those can lead to some incredible insights for a manager. We're happy to make those available, so we learn, the manager learns. It is a powerful flywheel of opportunity.” (play from 54:26)

This trade changes how general partners view hospital capital. To a top-quartile fund, institutional money is largely fungible. An LP that can vet product-market fit with pediatric surgeons and billing heads within 48 hours is not. That access opens doors to oversubscribed funds while protecting hospital leadership from purchasing unproven vendor tech.

Why It Matters

This setup marks a shift in how institutional capital justifies its existence to parent boards. As higher interest rates squeeze operating margins across hospital systems, healthcare systems can no longer afford to run isolated financial pools. Allocators who trade operating access for co-investments, top-tier access, and early product intelligence will compound value faster than passive balance sheet stewards.